Download PDF
CC BY 4.0 · Rev Bras Ginecol Obstet 2023; 45(12): e796-e807
DOI: 10.1055/s-0043-1772595
Review Article

Incidence and Outcomes Associated with Menopausal Status in COVID-19 Patients: A Systematic Review and Meta-analysis

Incidência e resultados associados ao estado da menopausa em pacientes com COVID-19: Uma revisão sistemática e metanálise
Abolfazl Akbari 
1   Mashhad University of Medical Sciences, Mashhad, Iran
,
Ahmadreza Zarifian 
1   Mashhad University of Medical Sciences, Mashhad, Iran
2   University Hospital Lewisham, King's College London, London, United Kingdom
,
Alireza Hadizadeh 
3   Tehran University of Medical Sciences, Tehran, Iran
,
Ezat Hajmolarezaei 
4   Mashhad University of Medical Sciences, Mashhad, Iran
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

Objective Menopause causes several changes in the body that may affect the response to COVID -19. We aimed to investigate the possible association between menopausal status and incidence and outcomes in COVID-19 patients.

Methods Combinations of keywordsCOVID-19, menopause, and estrogen were used to search the PubMed, Embase, Web-of-Science, and Scopus databases for articles reporting the incidence and outcomes of COVID-19 (discharge, length-of-admission, intensive care, or mortality) in premenopausal women, available through December 29, 2022. Data from studies comparing the incidence of COVID-19 infection with the age-matched male population were pooled and meta-analyzed using a random-effects model.

Results Overall, 1,564 studies were retrieved, of which 12 were finally included in the systematic review to compare disease outcomes, and 6 were meta-analyzed for the incidence of COVID-19 in premenopausal and postmenopausal women. All studies reported better COVID-19-associated outcomes in premenopausal women compared with postmenopausal women. After adjusting for confounding factors, three studies found better outcomes in postmenopausal women, and two found no association between menopausal status and COVID-19 outcomes. Our meta-analysis found a higher incidence of COVID-19 infection among premenopausal women than postmenopausal women, when compared with age-matched men (odds ratio = 1.270; 95% confidence interval: 1.086–1.486; p = 0.003).

Conclusion The incidence of COVID-19 was significantly higher in premenopausal women than in postmenopausal women when compared with age-matched men. Although premenopausal women may have more favorable COVID-19-associated outcomes, the presumed preventive effect of estrogens on the incidence and related outcomes of COVID-19 in premenopausal women cannot be proven at present. Further longitudinal studies comparing pre- and post-menopausal women are required to provide further insight into this matter.

Resumo

Objetivo A menopausa causa diversas alterações no corpo que podem afetar a resposta ao COVID-19. Nosso objetivo foi investigar a possível associação entre o status da menopausa e a incidência e os resultados em pacientes com COVID-19.

Métodos Combinações de palavras-chave COVID-19, menopausa e estrogênio foram usadas para pesquisar os bancos de dados PubMed, Embase, Web-of-Science e Scopus para artigos relatando a incidência e os resultados do COVID-19 (alta, tempo de internação, tratamento intensivo cuidados ou mortalidade) em mulheres na pré-menopausa, disponível até 29 de dezembro de 2022. Dados de estudos comparando a incidência de infecção por COVID-19 com a população masculina da mesma idade foram agrupados e meta-analisados usando um modelo de efeitos aleatórios.

Resultados No geral, 1.564 estudos foram recuperados, dos quais 12 foram finalmente incluídos na revisão sistemática para comparar os resultados da doença e 6 foram meta-analisados para a incidência de COVID-19 em mulheres na pré e pós-menopausa. Todos os estudos relataram melhores resultados associados ao COVID-19 em mulheres na pré-menopausa em comparação com mulheres na pós-menopausa. Após o ajuste para fatores de confusão, três estudos encontraram melhores resultados em mulheres na pós-menopausa e dois não encontraram associação entre o status da menopausa e os resultados do COVID-19. Nossa meta-análise encontrou uma maior incidência de infecção por COVID-19 entre mulheres na pré-menopausa do que mulheres na pós-menopausa, quando comparadas com homens da mesma idade (odds ratio = 1,270; intervalo de confiança de 95%: 1,086–1,486; p = 0,003).

Conclusão A incidência de COVID-19 foi significativamente maior em mulheres na pré-menopausa do que em mulheres na pós-menopausa quando comparadas com homens da mesma idade. Embora as mulheres na pré-menopausa possam ter resultados mais favoráveis associados ao COVID-19, o efeito preventivo presumido dos estrogênios na incidência e nos resultados relacionados ao COVID-19 em mulheres na pré-menopausa não pode ser comprovado no momento. Mas estudos longitudinais comparando mulheres pré e pós-menopausa são necessários para fornecer mais informações sobre este assunto.

Keywords

COVID-19 - menopause - estrogen - climacteric

Palavras-chave

COVID 19 - menopausa - estrogênio - climatério


Publication History

Received: 15 March 2023

Accepted: 14 July 2023

Article published online:
23 December 2023

© 2023. Federação Brasileira de Ginecologia e Obstetrícia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 

  • References

  • 1 Weekly epidemiological update on COVID-19 - 17 August 2022 2022 [105:[Available from: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19—17-august-2022
    PubMed
  • 2 Wu X, Liu L, Jiao J, Yang L, Zhu B, Li X. Characterisation of clinical, laboratory and imaging factors related to mild vs. severe covid-19 infection: a systematic review and meta-analysis. Ann Med 2020; 52 (07) 334-344
    CrossrefPubMedGoogle Scholar
  • 3 Akbari A, Fathabadi A, Razmi M, Zarifian A, Amiri M, Ghodsi A. et al. Characteristics, risk factors, and outcomes associated with readmission in COVID-19 patients: A systematic review and meta-analysis. Am J Emerg Med 2022; 52: 166-173
    CrossrefPubMedGoogle Scholar
  • 4 Parohan M, Yaghoubi S, Seraji A, Javanbakht MH, Sarraf P, Djalali M. Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. Aging Male 2020; 23 (05) 1416-1424
    CrossrefPubMedGoogle Scholar
  • 5 Abate BB, Kassie AM, Kassaw MW, Aragie TG, Masresha SA. Sex difference in coronavirus disease (COVID-19): a systematic review and meta-analysis. BMJ Open 2020; 10 (10) e040129
    CrossrefPubMedGoogle Scholar
  • 6 He H, Yang F, Liu X, Zeng X, Hu Q, Zhu Q. et al. Sex hormone ratio changes in men and postmenopausal women with coronary artery disease. Menopause 2007; 14 (3 Pt 1): 385-390
    CrossrefPubMedGoogle Scholar
  • 7 Nadkarni S, McArthur S. Oestrogen and immunomodulation: new mechanisms that impact on peripheral and central immunity. Curr Opin Pharmacol 2013; 13 (04) 576-581
    CrossrefPubMedGoogle Scholar
  • 8 Ma Q, Hao Z-W, Wang Y-F. The effect of estrogen in coronavirus disease 2019. Am J Physiol Lung Cell Mol Physiol 2021; 321 (01) L219-L227
    CrossrefPubMedGoogle Scholar
  • 9 Pazos MA, Kraus TA, Muñoz-Fontela C, Moran TM. Estrogen mediates innate and adaptive immune alterations to influenza infection in pregnant mice. PLoS One 2012; 7 (07) e40502
    CrossrefPubMedGoogle Scholar
  • 10 Robinson DP, Lorenzo ME, Jian W, Klein SL. Elevated 17β-estradiol protects females from influenza A virus pathogenesis by suppressing inflammatory responses. PLoS Pathog 2011; 7 (07) e1002149
    CrossrefPubMedGoogle Scholar
  • 11 Al-Lami RA, Urban RJ, Volpi E, Algburi AMA, Baillargeon J. Sex Hormones and Novel Corona Virus Infectious Disease (COVID-19). Mayo Clin Proc 2020; 95 (08) 1710-1714
    CrossrefPubMedGoogle Scholar
  • 12 Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M. et al; PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015; 4 (01) 1
    CrossrefPubMedGoogle Scholar
  • 13 Morrison A, Polisena J, Husereau D, Moulton K, Clark M, Fiander M. et al. The effect of English-language restriction on systematic review-based meta-analyses: a systematic review of empirical studies. Int J Technol Assess Health Care 2012; 28 (02) 138-144
    CrossrefPubMedGoogle Scholar
  • 14 Moola S, Munn Z, Tufanaru C. et al. Chapter 7: Systematic reviews of etiology and risk. Joanna briggs institute reviewer's manual. The Joanna Briggs Institute; 2017: 5
    Google Scholar
  • 15 Ding T, Zhang J, Wang T, Cui P, Chen Z, Jiang J. et al. Potential Influence of Menstrual Status and Sex Hormones on Female Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Cross-sectional Multicenter Study in Wuhan, China. Clin Infect Dis 2021; 72 (09) e240-e248
    CrossrefPubMedGoogle Scholar
  • 16 Wang X-W, Hu H, Xu Z-Y, Zhang G-K, Yu Q-H, Yang H-L. et al. Association of menopausal status with COVID-19 outcomes: a propensity score matching analysis. Biol Sex Differ 2021; 12 (01) 16
    CrossrefPubMedGoogle Scholar
  • 17 Mishra N, Sharma R, Mishra P, Singh M, Seth S, Deori T. et al. COVID-19 and Menstrual Status: Is Menopause an Independent Risk Factor for SARS Cov-2?. J Midlife Health 2020; 11 (04) 240-249
    PubMedGoogle Scholar
  • 18 O'Brien J, Du KY, Peng C. Incidence, clinical features, and outcomes of COVID-19 in Canada: impact of sex and age. J Ovarian Res 2020; 13 (01) 137
    CrossrefPubMedGoogle Scholar
  • 19 Seeland U, Coluzzi F, Simmaco M, Mura C, Bourne PE, Heiland M. et al. Evidence for treatment with estradiol for women with SARS-CoV-2 infection. BMC Med 2020; 18 (01) 369
    CrossrefPubMedGoogle Scholar
  • 20 Sha J, Qie G, Yao Q, Sun W, Wang C, Zhang Z. et al. Sex Differences on Clinical Characteristics, Severity, and Mortality in Adult Patients With COVID-19: A Multicentre Retrospective Study. Front Med (Lausanne) 2021; 8: 607059
    CrossrefPubMedGoogle Scholar
  • 21 Garg R, Agrawal P, Gautam A, Pursani N, Agarwal M, Agarwal A. et al. COVID-19 Outcomes in Postmenopausal and Perimenopausal Females: Is Estrogen Hormone Attributing to Gender Differences?. J Midlife Health 2020; 11 (04) 250-256
    PubMedGoogle Scholar
  • 22 Liu D, Ding H-L, Chen Y, Chen D-H, Yang C, Yang L-M. et al. Comparison of the clinical characteristics and mortalities of severe COVID-19 patients between pre- and post-menopause women and age-matched men. Aging (Albany NY) 2021; 13 (18) 21903-21913
    CrossrefPubMedGoogle Scholar
  • 23 Wang M, Jiang N, Li C, Wang J, Yang H, Liu L. et al. Sex-Disaggregated Data on Clinical Characteristics and Outcomes of Hospitalized Patients With COVID-19: A Retrospective Study. Front Cell Infect Microbiol 2021; 11: 680422
    CrossrefPubMedGoogle Scholar
  • 24 Ferretti VV, Klersy C, Bruno R, Cutti S, Nappi RE. Men with COVID-19 die. Women survive. Maturitas 2022; 158: 34-36
    CrossrefPubMedGoogle Scholar
  • 25 Toure T, Ravindra L, Monteiro F, Gopalakrishnan G. PMON201 The Impact of Menopause on Poor Outcomes in Hospitalized Patients with COVID-19 Infection. J Endocr Soc 2022; 6 (01) 686
    CrossrefPubMedGoogle Scholar
  • 26 Costeira R, Lee KA, Murray B, Christiansen C, Castillo-Fernandez J, Lochlainn MN. et al. Estrogen and COVID-19 symptoms: Associations in women from the COVID Symptom Study. PLoS One 2021; 16 (09) e0257051
    CrossrefPubMedGoogle Scholar
  • 27 Biswas M, Rahaman S, Biswas TK, Haque Z, Ibrahim B. Association of Sex, Age, and Comorbidities with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis. Intervirology 2020; 64 (01) 1-12
    PubMedGoogle Scholar
  • 28 Li LQ, Huang T, Wang YQ, Wang Z-P, Liang Y, Huang T-B. et al. COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol 2020; 92 (06) 577-583
    CrossrefPubMedGoogle Scholar
  • 29 Rozenberg S, Vandromme J, Martin C. Are we equal in adversity? Does Covid-19 affect women and men differently?. Maturitas 2020; 138: 62-68
    CrossrefPubMedGoogle Scholar
  • 30 Shaw AC, Goldstein DR, Montgomery RR. Age-dependent dysregulation of innate immunity. Nat Rev Immunol 2013; 13 (12) 875-887
    CrossrefPubMedGoogle Scholar
  • 31 Suba Z. Prevention and therapy of COVID-19 via exogenous estrogen treatment for both male and female patients. J Pharm Pharm Sci 2020; 23 (01) 75-85
    CrossrefPubMedGoogle Scholar
  • 32 Stelzig KE, Canepa-Escaro F, Schiliro M, Berdnikovs S, Prakash YS, Chiarella SE. Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 2020; 318 (06) L1280-L1281
    CrossrefPubMedGoogle Scholar
  • 33 Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol 2021; 93 (01) 250-256
    CrossrefPubMedGoogle Scholar
  • 34 Akbari A, Razmi M, Sedaghat A, Dana SMMA, Amiri M, Halvani AM. et al. Comparative effectiveness of pharmacological interventions on mortality and the average length of hospital stay of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials. Expert Rev Anti Infect Ther 2022; 20 (04) 585-609
    CrossrefPubMedGoogle Scholar
  • 35 Li F, Boon ACM, Michelson AP, Foraker RE, Zhan M, Payne PRO. Estrogen hormone is an essential sex factor inhibiting inflammation and immune response in COVID-19. Sci Rep 2022; 12 (01) 9462
    CrossrefPubMedGoogle Scholar
  • 36 Murphy AJ, Guyre PM, Pioli PA. Estradiol suppresses NF-kappa B activation through coordinated regulation of let-7a and miR-125b in primary human macrophages. J Immunol 2010; 184 (09) 5029-5037
    CrossrefPubMedGoogle Scholar
  • 37 Beagley KW, Gockel CM. Regulation of innate and adaptive immunity by the female sex hormones oestradiol and progesterone. FEMS Immunol Med Microbiol 2003; 38 (01) 13-22
    CrossrefPubMedGoogle Scholar
  • 38 Moulton VR. Sex Hormones in Acquired Immunity and Autoimmune Disease. Front Immunol 2018; 9: 2279
    CrossrefPubMedGoogle Scholar
  • 39 Al-Kuraishy HM, Al-Gareeb AI, Faidah H, Al-Maiahy TJ, Cruz-Martins N, Batiha GE-S. The Looming Effects of Estrogen in Covid-19: A Rocky Rollout. Front Nutr 2021; 8: 649128
    CrossrefPubMedGoogle Scholar
  • 40 Shabbir S, Hafeez A, Rafiq MA, Khan MJ. Estrogen shields women from COVID-19 complications by reducing ER stress. Med Hypotheses 2020; 143: 110148
    CrossrefPubMedGoogle Scholar
  • 41 Channappanavar R, Fett C, Mack M, Ten Eyck PP, Meyerholz DK, Perlman S. Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection. J Immunol 2017; 198 (10) 4046-4053
    CrossrefPubMedGoogle Scholar
  • 42 Pirhadi R, Sinai Talaulikar V, Onwude J, Manyonda I. Could Estrogen Protect Women From COVID-19?. J Clin Med Res 2020; 12 (10) 634-639
    CrossrefPubMedGoogle Scholar
  • 43 Tam A, Wadsworth S, Dorscheid D, Man SF, Sin DD. Estradiol increases mucus synthesis in bronchial epithelial cells. PLoS One 2014; 9 (06) e100633
    CrossrefPubMedGoogle Scholar
  • 44 Di Stadio A, Della Volpe A, Ralli M, Ricci G. Gender differences in COVID-19 infection. The estrogen effect on upper and lower airways. Can it help to figure out a treatment?. Eur Rev Med Pharmacol Sci 2020; 24 (10) 5195-5196
    CrossrefPubMedGoogle Scholar
  • 45 Zafari Zangeneh F, Sarmast Shoushtari M. Estradiol and COVID-19: Does 17-Estradiol Have an Immune-Protective Function in Women Against Coronavirus?. J Family Reprod Health 2021; 15 (03) 150-159
    PubMedGoogle Scholar
  • 46 Dambha-Miller H, Hinton W, Wilcox CR, Joy M, Feher M, de Lusignan S. Mortality in COVID-19 among women on hormone replacement therapy: a retrospective cohort study. Fam Pract 2022; 39 (06) 1049-1055
    CrossrefPubMedGoogle Scholar
  • 47 Popkin BM, Du S, Green WD, Beck MA, Algaith T, Herbst CH. et al. Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships. Obes Rev 2020; 21 (11) e13128
    CrossrefPubMedGoogle Scholar
  • 48 Bechmann N, Barthel A, Schedl A, Herzig S, Varga Z, Gebhard C. et al. Sexual dimorphism in COVID-19: potential clinical and public health implications. Lancet Diabetes Endocrinol 2022; 10 (03) 221-230
    CrossrefPubMedGoogle Scholar
  • 49 Lagou V, Mägi R, Hottenga J-J, Grallert H, Perry JRB, Bouatia-Naji N. et al; Meta-Analyses of Glucose and Insulin-related traits Consortium (MAGIC). Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability. Nat Commun 2021; 12 (01) 24
    CrossrefPubMedGoogle Scholar
  • 50 Speyer CL, Rancilio NJ, McClintock SD, Crawford JD, Gao H, Sarma JV. et al. Regulatory effects of estrogen on acute lung inflammation in mice. Am J Physiol Cell Physiol 2005; 288 (04) C881-C890
    CrossrefPubMedGoogle Scholar
  • 51 Subbiah MT. Estrogen replacement therapy and cardioprotection: mechanisms and controversies. Brazilian journal of medical and biological research =. Rev Bras Pesqui Med Biol 2002; 35 (03) 271-276
    PubMedGoogle Scholar
  • 52 Schierbeck LL, Rejnmark L, Tofteng CL, Stilgren L, Eiken P, Mosekilde L. et al. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ 2012; 345: e6409
    CrossrefPubMedGoogle Scholar
  • 53 Rovinski D, Ramos RB, Fighera TM, Casanova GK, Spritzer PM. Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis. Thromb Res 2018; 168: 83-95
    CrossrefPubMedGoogle Scholar
  • 54 Suh YJ, Hong H, Ohana M, Bompard F, Revel M-P, Valle C. et al. Pulmonary Embolism and Deep Vein Thrombosis in COVID-19: A Systematic Review and Meta-Analysis. Radiology 2021; 298 (02) E70-E80
    CrossrefPubMedGoogle Scholar
  • 55 Zhu Z, Cai T, Fan L, Lou K, Hua X, Huang Z. et al. Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019. Int J Infect Dis 2020; 95: 332-339
    CrossrefPubMedGoogle Scholar
  • 56 Honour JW. Biochemistry of the menopause. Ann Clin Biochem 2018; 55 (01) 18-33
    CrossrefPubMedGoogle Scholar
  • 57 Akbari H, Tabrizi R, Lankarani KB, Aria H, Vakili S, Asadian F. et al. The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. Life Sci 2020; 258: 118167
    CrossrefPubMedGoogle Scholar